Cooper Medical School of Rowan University, Camden, NJ, United States of America.
Philadelphia College of Osteopathic Medicine, Philadelphia, US.
J Stroke Cerebrovasc Dis. 2022 Nov;31(11):106782. doi: 10.1016/j.jstrokecerebrovasdis.2022.106782. Epub 2022 Sep 18.
The lack of superiority of anticoagulation over antiplatelet therapy in embolic stroke of undetermined source (ESUS) may be in part due to the misclassification of radiographic ESUS patterns as cardioembolic. In this imaging analysis, we sought to differentiate clinical and radiographic patterns of ESUS patients from patterns in patients with a highly probable cardioembolic source.
MATERIALS & METHODS: A prospective registry of consecutive adults with acute infarction on diffusion-weighted magnetic resonance imaging was queried. Patients with infarctions due to small vessel disease, large vessel disease, and other causes were excluded. Multivariable logistic regression was used to identify independent predictors of two potentially embolic patterns: (1) multifocal and (2) cortical lesions, comparing patients with ESUS against those with atrial fibrillation (AF).
Among 1243 screened patients, 343 (27.6%) experienced strokes due to ESUS or AF. Prior to the index stroke, patients with AF as compared to ESUS were older (median 75 vs. 65, p<0.01) and had more heart failure (25.9% vs. 8.4%, p<0.01). The odds of multifocal infarction were the same between patients with ESUS and both AF subtypes (p>0.05), however, cortical involvement was more associated with both AF versus ESUS (77.7% vs. 65.7%, P=0.02). A higher Fazekas grade of white matter disease was inversely associated with cortical infarction among included patients (aOR 0.77, 95% CI 0.62-0.96).
Cortical infarctions were twice as common among patients with AF versus ESUS. Subcortical infarct topography was strongly associated with chronic microvascular ischemic changes and therefore may not represent embolic phenomena. Larger-scale investigations are warranted to discern whether large or multifocal subcortical infarcts ought to be excluded from the ESUS designation.
在未确定来源的栓塞性脑卒中(ESUS)中,抗凝治疗并不优于抗血小板治疗,部分原因可能是将放射影像学 ESUS 模式错误分类为心源性栓塞。在这项影像学分析中,我们试图将 ESUS 患者的临床和放射影像学模式与具有高度可能的心源性栓塞源的患者的模式区分开来。
对连续接受磁共振弥散加权成像的急性脑梗死成人患者进行前瞻性登记。排除因小血管疾病、大血管疾病和其他原因导致的梗死患者。采用多变量逻辑回归分析方法,比较 ESUS 患者与心房颤动(AF)患者,以确定两种潜在栓塞模式的独立预测因素:(1)多灶性和(2)皮质性病变。
在筛选出的 1243 例患者中,有 343 例(27.6%)发生了 ESUS 或 AF 导致的脑卒中。在首发脑卒中之前,与 ESUS 患者相比,AF 患者年龄更大(中位数 75 岁 vs. 65 岁,p<0.01)且心力衰竭更多(25.9% vs. 8.4%,p<0.01)。ESUS 患者与两种 AF 亚型患者的多灶性梗死发生率相同(p>0.05),然而,皮质病变与 AF 相比更与 ESUS 相关(77.7% vs. 65.7%,P=0.02)。在纳入的患者中,脑白质疾病的 Fazekas 分级越高,皮质梗死的发生率越低(OR 0.77,95%CI 0.62-0.96)。
AF 患者的皮质性梗死发生率是 ESUS 患者的两倍。皮质下梗死的部位与慢性微血管缺血性改变密切相关,因此可能不是栓塞现象。需要进行更大规模的研究,以确定是否应将大或多灶性皮质下梗死排除在 ESUS 诊断之外。